Malignant disease occurs when neoplastic cells abandon their primary site of accretion, cross tissue boundaries and penetrate the vasculature to colonize distant sites. This process - metastasis - is the aberrant counterpart of a physiological programme for organ regeneration and maintenance. Scatter factors and semaphorins, together with their receptors, help to orchestrate this programme. What are the differences between physiological and pathological activation of these signalling molecules, and can we exploit them therapeutically to prevent metastasis?
|Number of pages||12|
|Journal||Nature Reviews Cancer|
|Publication status||Published - Apr 2002|
ASJC Scopus subject areas
- Cancer Research